Amanote Research

Amanote Research

    RegisterSign In

Nonalcoholic Fatty Liver Disease: Is It Time for Combination Treatment and a Diabetes-Like Approach?

Hepatology - United States
doi 10.1002/hep.29897
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineHepatology
Date

July 1, 2018

Authors
Stergios A. PolyzosJannis KountourasSotiris AnastasiadisMichael DoulberisPanagiotis Katsinelos
Publisher

Wiley


Related search

Nonalcoholic Fatty Liver Disease and COPD: Is It Time to Cross the Diaphragm?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Nonalcoholic Fatty Liver Disease

Hypertension
Internal Medicine
2020English

Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease—Is There a Link?

Gastroenterology Research and Practice
HepatologyGastroenterology
2014English

Nonalcoholic Fatty Liver Disease

Gastroenterology
HepatologyGastroenterology
2002English

Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Clinics in Liver Disease
Hepatology
2018English

Treatment of Nonalcoholic Fatty Liver Disease: Role of AMPK

American Journal of Physiology - Endocrinology and Metabolism
EndocrinologyPhysiologyMetabolismDiabetes
2016English

Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes

Medical Council
2016English

Ethnicity and Nonalcoholic Fatty Liver Disease

Hepatology
MedicineHepatology
2012English

Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes

Hepatology
MedicineHepatology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy